ETS

(4S-TRANS)-4-(ETHYLAMINO)-5,6-DIHYDRO-6-METHYL-4H-THIENO(2,3-B)THIOPYRAN-2-SULFONAMIDE-7,7-DIOXIDE

Find entries where: ETS

is present as a standalone ligand in 6 entries

Find related ligands:

Chemical Component Summary
Name	(4S-TRANS)-4-(ETHYLAMINO)-5,6-DIHYDRO-6-METHYL-4H-THIENO(2,3-B)THIOPYRAN-2-SULFONAMIDE-7,7-DIOXIDE
Synonyms	Dorzolamide
Identifiers	(4S,6S)-4-(ethylamino)-6-methyl-7,7-bis(oxidanylidene)-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide
Formula	C₁₀ H₁₆ N₂ O₄ S₃
Molecular Weight	324.44
Type	NON-POLYMER
Isomeric SMILES	CCN[C@H]1C[C@@H](S(=O)(=O)c2c1cc(s2)S(=O)(=O)N)C
InChI	InChI=1S/C10H16N2O4S3/c1-3-12-8-4-6(2)18(13,14)10-7(8)5-9(17-10)19(11,15)16/h5-6,8,12H,3-4H2,1-2H3,(H2,11,15,16)/t6-,8-/m0/s1
InChIKey	IAVUPMFITXYVAF-XPUUQOCRSA-N

Chemical Details
Formal Charge	0
Atom Count	35
Chiral Atom Count	2
Bond Count	36
Aromatic Bond Count	5

Drug Info: DrugBank

DrugBank ID	DB00869
Name	Dorzolamide
Groups	approved
Description	Dorzolamide is a non-bacteriostatic sulfonamide derivative [A1304] and topical carbonic anhydrase (CA) inhibitor that treats elevated intraocular pressure (IOP) associated with open-angle glaucoma and ocular hypertension.[L11377] It works by blocking an enzyme in the ciliary process that regulates ion balance and fluid pressure in the eyes.[A1303] Unlike oral CA inhibitors, dorzolamide has negligible effects of acid-base or electrolyte disturbances and other systemic adverse effects.[A1304] First marketed in 1995,[A190624] dorzolamide is available in ophthalmic solutions as monotherapy marketed as Trusopt [L11377] or in combination with [timolol] as Cosopt PF.[L11380]
Synonyms	Dorzolamid Dorzolamide 4S,6S-dorzolamide 4-ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide Dorzolamidum (4S,trans)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide Dorzolamide hydrochloride Dorzolamida 4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide (4S,6S)-4-ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide
Brand Names	Med-dorzolamide Dorzolamide PF Apo-dorzo-timop Priva-dorzolamide-timolol Dorzolamide-timolol Dorzolamide Hydrochloride Ophthalmic Solution 2%, 10mL Ophthalmic Solution 2%, 10mL Dorzolamide Hydrochloride-Timolol Maleate Dorzolamide hydrochloride Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Dorzolamide and Timolol Eye Drops BP Dorzolamide Hydrochloride Timolol Maletae Cosopt Dorzolamide Eye Drops BP Dorzolamide Hydrochloride and Timolol Maleate Riva-dorzolamide Dorzolamide Hydrochloride Ophthalmic Solution Mylan-dorzolamide/timolol Tim-Brim-Dor PF Duokopt Trusopt Riva-dorzolamide/timolol Brim-Dor PF PMS-dorzolamide-timolol Van-dorzolamide-timolol Dorzolamide Hydrochloride Dorzolamide HCl Jamp-dorzolamide Jamp Dorzolamide-timolol Dorzolamide and Timolol Tim-Brim-Dor-Lat Dorzolamide hydrochloride and timolol maleate Sandoz Dorzolamide Cosopt PF Tim-Dor PF Act Dorzotimolol Apo-dorzolamide M-dorzolamide-timolol Dorzolamide HCl and Timolol Maleate Trusopt Preservative-free Cosopt Preservative-free Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Solution Dorzolamide Hydrochloride-timolol Maleate Sandoz Dorzolamide/timolol Dorzolamide HCl /Timolol Maleate Dorzolamide Hydrochloride Ophthalmic Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution Dorzolamide Med-dorzolamide-timolol Dorzolamide-timolol PF Tim-Dor-Lat Dorzolamide Hydrochloride and Timolol Maleate Preservative Free Teva-dorzotimol DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE Dorzolamide Hydrochloride-Timolol Maleate Ophthalmic Solution Sterile Ophthalmic Solution Dorzolamide Hydrochloride Timolol Maleate Ag-dorzolamide Timolol Mint-dorzolamide/timolol
Indication	Dorzolamide is indicated for the management of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.[L11377] It can also be used in combination with [timolol] for the same indication in patients who are insufficiently responsive to ophthalmic beta-blockers.[L11380] Its pre-operative use was also investigated to prevent elevated intraocular pressure after neodynium yttrium aluminum garnet laser posterior capsulotomy.[A190183]
Categories	Amides Antiglaucoma Preparations and Miotics Antihypertensive Agents Carbonic Anhydrase Inhibitors Cardiovascular Agents Cytochrome P-450 CYP2C9 Substrates Cytochrome P-450 CYP2E1 Substrates Cytochrome P-450 Substrates Diuretics Drugs that are Mainly Renally Excreted Enzyme Inhibitors Genito Urinary System and Sex Hormones Gynecological Antiinfectives and Antiseptics Intraocular Pressure, drug effects Ophthalmologicals Sensory Organs Sulfonamides Sulfones Sulfur Compounds
ATC-Code	G01AE10 S01EC03
CAS number	120279-96-1

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Carbonic anhydrase 2	MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVS...	unknown	inhibitor
Carbonic anhydrase 4	MRMLLALLALSAARPSASAESHWCYEVQAESSNYPCLVPVKWGGNCQKDR...	unknown	inhibitor
Carbonic anhydrase 1	MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISV...	unknown	inhibitor
Carbonic anhydrase 3	MAKEWGYASHNGPDHWHELFPNAKGENQSPVELHTKDIRHDPSLQPWSVS...	unknown	inhibitor
Cytochrome P450 2C9	MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...	unknown	substrate
Cytochrome P450 2B1	MEPTILLLLALLVGFLLLLVRGHPKSRGNFPPGPRPLPLLGNLLQLDRGG...	unknown	substrate
Cytochrome P450 2E1	MSALGVTVALLVWAAFLLLVSMWRQVHSSWNLPPGPFPLPIIGNLFQLEL...	unknown	substrate
Cytochrome P450 3A2	MDLLSALTLETWVLLAVILVLLYRLGTHRHGIFKKQGIPGPKPLPFLGTV...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682